ADN-1184 a monoaminergic ligand with 5-HT6/7receptor antagonist activity: pharmacological profile and potential therapeutic utility
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ADN-1184 a monoaminergic ligand with 5-HT6/7receptor antagonist activity: pharmacological profile and potential therapeutic utility
Authors
Keywords
-
Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume 171, Issue 4, Pages 973-984
Publisher
Wiley
Online
2013-11-07
DOI
10.1111/bph.12509
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Involvement of an Altered 5-HT6 Receptor Function in Behavioral Symptoms of Alzheimer's Disease
- (2017) Beatriz Marcos et al. JOURNAL OF ALZHEIMERS DISEASE
- Management of the behavioral and psychological symptoms of dementia
- (2016) Elizabeth Hersch Clinical Interventions in Aging
- The Concise Guide to PHARMACOLOGY 2013/14: Overview
- (2013) Stephen P.H. Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- N-Methyl D-Aspartate (NMDA) Receptor Antagonists and Memantine Treatment for Alzheimer’s Disease, Vascular Dementia and Parkinson’s Disease
- (2013) David Olivares et al. Current Alzheimer Research
- Impact of safety warnings on antipsychotic prescriptions in dementia: Nothing has changed but the years and the substances
- (2013) Jana Schulze et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Expression of α1-adrenergic receptors in rat prefrontal cortex: cellular co-localization with 5-HT2A receptors
- (2012) Noemí Santana et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- 5-HT6 receptor blockade differentially affects scopolamine-induced deficits of working memory, recognition memory and aversive learning in mice
- (2012) Virginie Da Silva Costa-Aze et al. PSYCHOPHARMACOLOGY
- Cognitive Effects of Atypical Antipsychotic Medications in Patients With Alzheimer's Disease: Outcomes From CATIE-AD
- (2011) Cheryl L.P. Vigen et al. AMERICAN JOURNAL OF PSYCHIATRY
- Animal models of schizophrenia
- (2011) CA Jones et al. BRITISH JOURNAL OF PHARMACOLOGY
- Efficacy and Comparative Effectiveness of Atypical Antipsychotic Medications for Off-Label Uses in Adults
- (2011) Alicia Ruelaz Maher et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pharmacological Blockade of Serotonin 5-HT7 Receptor Reverses Working Memory Deficits in Rats by Normalizing Cortical Glutamate Neurotransmission
- (2011) Pascal Bonaventure et al. PLoS One
- Comparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties
- (2011) Adrian Newman-Tancredi et al. PSYCHOPHARMACOLOGY
- Guidelines for reporting experiments involving animals: the ARRIVE guidelines
- (2010) JC McGrath et al. BRITISH JOURNAL OF PHARMACOLOGY
- Animal research: Reporting in vivo experiments: The ARRIVE guidelines
- (2010) Carol Kilkenny et al. BRITISH JOURNAL OF PHARMACOLOGY
- Validation and pharmacological characterisation of MK-801-induced locomotor hyperactivity in BALB/C mice as an assay for detection of novel antipsychotics
- (2010) Andrea M. Bradford et al. PSYCHOPHARMACOLOGY
- Antidepressant and anxiolytic effects of selective 5-HT6 receptor agonists in rats
- (2010) Gregory V. Carr et al. PSYCHOPHARMACOLOGY
- Second-Generation Antipsychotic Drugs and Extrapyramidal Side Effects: A Systematic Review and Meta-analysis of Head-to-Head Comparisons
- (2010) Christine Rummel-Kluge et al. SCHIZOPHRENIA BULLETIN
- Association between HTR2C polymorphisms and metabolic syndrome in patients with schizophrenia treated with atypical antipsychotics
- (2010) Ya Mei Bai et al. SCHIZOPHRENIA RESEARCH
- Prazosin for the Treatment of Behavioral Symptoms in Patients With Alzheimer Disease With Agitation and Aggression
- (2009) Lucy Y. Wang et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Effects of SB-269970, a 5-HT7 receptor antagonist, in mouse models predictive of antipsychotic-like activity
- (2009) Ruggero Galici et al. BEHAVIOURAL PHARMACOLOGY
- Conditioned Avoidance Response in the Development of New Antipsychotics
- (2009) M-L. Wadenberg CURRENT PHARMACEUTICAL DESIGN
- Strategies for pharmacotherapy of schizophrenia
- (2009) J. Arnt et al. DRUGS OF THE FUTURE
- The serotonin 5-HT6receptor: a viable drug target for treating cognitive deficits in Alzheimer’s disease
- (2009) Werner J Geldenhuys et al. Expert Review of Neurotherapeutics
- Use and misuse of antipsychotic drugs in patients with dementia in Alzheimer special care units
- (2009) Alessandro Nobili et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Procognitive 5-HT6 antagonists in the rat forced swimming test: Potential therapeutic utility in mood disorders associated with Alzheimer's disease
- (2009) Kazufumi Hirano et al. LIFE SCIENCES
- Metabolic side effects of antipsychotic drug treatment – pharmacological mechanisms
- (2009) Gavin P Reynolds et al. PHARMACOLOGY & THERAPEUTICS
- Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo
- (2009) Atheir I. Abbas et al. PSYCHOPHARMACOLOGY
- The 5-HT7 receptor and disorders of the nervous system: an overview
- (2009) Peter B. Hedlund PSYCHOPHARMACOLOGY
- Antipsychotics for the Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD)
- (2008) Rosa Liperoti et al. Current Neuropharmacology
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started